Segment Information (Tables)

9 Months Ended

Sep. 30, 2024

Schedule of Financial Data by Reportable Segment

Financial data by reportable segment for the three and nine months ended September 30, 2024 and 2023 is as follows:


			Carelon
	Health Benefits		CarelonRx		Carelon Services		Total		Corporate & Other		Eliminations		Total
Three Months Ended September 30, 2024
Premiums	$	36,448	$	—	$	680	$	680	$	—	$	(319)	$	36,809
Product revenue	—		5,887		—		5,887		—		—		5,887
Service fees	1,830		2		201		203		(10)		—		2,023
Operating revenue - unaffiliated	38,278		5,889		881		6,770		(10)		(319)		44,719
Operating revenue - affiliated	—		3,254		3,757		7,011		84		(7,095)		—
Operating revenue - total	$	38,278	$	9,143	$	4,638	$	13,781	$	74	$	(7,414)	$	44,719

Operating gain (loss)	$	1,604	$	619	$	184	$	803	$	(999)	$	—	$	1,408
Depreciation and amortization of property and equipment	—		—		—		—		231		—		231

Three Months Ended September 30, 2023
Premiums	$	34,934	$	—	$	422	$	422	$	—	$	(97)	$	35,259
Product revenue	—		5,177		—		5,177		—		—		5,177
Service fees	1,810		4		218		222		12		—		2,044
Operating revenue - unaffiliated	36,744		5,181		640		5,821		12		(97)		42,480
Operating revenue - affiliated	—		3,337		2,869		6,206		83		(6,289)		—
Operating revenue - total	$	36,744	$	8,518	$	3,509	$	12,027	$	95	$	(6,386)	$	42,480

Operating gain (loss)	$	1,834	$	477	$	192	$	669	$	(747)	$	—	$	1,756
Depreciation and amortization of property and equipment	—		—		—		—		220		—		220



			Carelon
	Health Benefits		CarelonRx		Carelon Services		Total		Corporate & Other		Eliminations		Total
Nine Months Ended September 30, 2024
Premiums	$	106,926	$	—	$	1,882	$	1,882	$	—	$	(887)	$	107,921
Product revenue	—		15,916		—		15,916		—		—		15,916
Service fees	5,769		4		594		598		11		—		6,378
Operating revenue - unaffiliated	112,695		15,920		2,476		18,396		11		(887)		130,215
Operating revenue - affiliated	—		10,064		10,716		20,780		312		(21,092)		—
Operating revenue - total	$	112,695	$	25,984	$	13,192	$	39,176	$	323	$	(21,979)	$	130,215

Operating gain (loss)	$	6,036	$	1,639	$	682	$	2,321	$	(1,168)	$	—	$	7,189
Depreciation and amortization of property and equipment	—		—		—		—		687		—		687

Nine Months Ended September 30, 2023
Premiums	$	106,701	$	—	$	1,261	$	1,261	$	—	$	(246)	$	107,716
Product revenue	—		14,058		—		14,058		—		—		14,058
Service fees	5,323		4		627		631		27		—		5,981
Operating revenue - unaffiliated	112,024		14,062		1,888		15,950		27		(246)		127,755
Operating revenue - affiliated	—		10,946		8,685		19,631		271		(19,902)		—
Operating revenue - total	$	112,024	$	25,008	$	10,573	$	35,581	$	298	$	(20,148)	$	127,755

Operating gain (loss)	$	6,121	$	1,485	$	578	$	2,063	$	(969)	$	—	$	7,215
Depreciation and amortization of property and equipment	—		—		—		—		659		—		659

Schedule of Reconciliation of Reportable Segments Operating Revenues to Total Revenues Reported in the Consolidated Statements of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and nine months ended September 30, 2024 and 2023 is as follows:


	Three Months Ended September 30				Nine Months Ended September 30
	2024		2023		2024		2023
Reportable segments’ operating revenue	$	44,719	$	42,480	$	130,215	$	127,755
Net investment income	551		493		1,524		1,296
Net losses on financial instruments	(125)		(124)		(371)		(358)
(Loss) gain on sale of business	(39)		—		201		—
Total revenues	$	45,106	$	42,849	$	131,569	$	128,693

Schedule of Reconciliation of Income Before Income Tax Expense to Reportable Segments Operating Gain Included in the Consolidated Statements of Income

A reconciliation of income before income tax expense to reportable segments’ operating gain included in our consolidated statements of income for the three and nine months ended September 30, 2024 and 2023 is as follows:


	Three Months Ended September 30				Nine Months Ended September 30
	2024		2023			2024		2023

Income before income tax expense	$	1,373	$	1,654		$	7,298	$	6,714
Net investment income	(551)		(493)			(1,524)		(1,296)
Net losses on financial instruments	125		124			371		358
Loss (gain) on sale of business	39		—			(201)		—
Interest expense	300		259			845		771
Amortization of other intangible assets	122		212			400		668

Reportable segments’ operating gain	$	1,408	$	1,756		$	7,189	$	7,215